Charlotte Munkstrup

Charlotte Munkstrup

Auto-generated profile, based on publicly available information

Charlotte Munkstrup

Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2023 in Eurosurveillance
Verified
Journal Article
Open access
TJThor Bech Johannesen
Thor Bech Johannesen
CMCharlotte Munkstrup
Charlotte Munkstrup
SESofie Edslev
Sofie Edslev
SBSharmin Baig
Sharmin Baig
SNStine Nielsen
Stine Nielsen
MSMarc Stegger
Marc Stegger
A highly virulent sub-lineage of the Streptococcus pyogenes M1 clone has been rapidly expanding throughout Denmark since late 2022 and now accounts for 30% of the new invasive group A streptococcal infections. We aimed to investigate whether a shift in variant composition can account for the high incidence rates observed over winter 2022/23, or if these are better explained by the impact of COVID-19-related restrictions on population immunity and carriage of group A Streptococcus.

5 January 2023 in Eurosurveillance
Verified
Journal Article
Open access
CMCharlotte Munkstrup
Charlotte Munkstrup
FLFrederikke Kristensen Lomholt
Frederikke Kristensen Lomholt
HEHanne-Dorthe Emborg
Hanne-Dorthe Emborg
KMKarina Lauenborg Møller
Karina Lauenborg Møller
JKJesper Schak Krog
Jesper Schak Krog
LVLasse S. Vestergaard
Lasse S. Vestergaard
In the autumn of 2022, Denmark witnessed the second out-of-season epidemic of respiratory syncytial virus (RSV) following widespread societal preventive measures implemented against the coronavirus disease (COVID-19) pandemic during 2020 and 2021. Admissions peaked at twice the level of pre-pandemic seasons. Especially infants below 6 months of age were affected, but also adults over 45 years of age. The current epidemic is dominated by RSV subtype B, unlike the major RSV summer epidemic in 2021 dominated by RSV subtype A.

5 February 2024 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
FLFrederikke Kristensen Lomholt
Frederikke Kristensen Lomholt
HEHanne-Dorthe Emborg
Hanne-Dorthe Emborg
SNSarah Kristine Nørgaard
Sarah Kristine Nørgaard
JNJens Nielsen
Jens Nielsen
CMCharlotte Munkstrup
Charlotte Munkstrup
LVLasse Skafte Vestergaard
Lasse Skafte Vestergaard
Background: When coronavirus disease 2019 (COVID-19) restrictions were lifted in Denmark in the spring of 2021, a surge in respiratory syncytial virus (RSV) cases followed, causing a large out-of-season epidemic. This study aims to investigate the summer epidemic compared with 3 typical pre-COVID-19 RSV winter seasons using Danish registers to identify RSV cases, RSV-related admissions, and use of intensive care treatment. Methods: Incidence rates (IR) per 1000 person-years for RSV cases, RSV-related admissions, and intensive care treatment were calculated with 95% confidence interval (CI) for each season, stratified by age groups and incidence rate ratios (IRR) with 95% CI were calculated to compare the summer epidemic with the winter season for 2019-2020. Results: In the summer epidemic, the IR of RSV cases and admissions exceeded previous winter seasons for all age groups. The highest increases in IRs were seen among children aged 2 to 3 years and 4 to 5 years. The IRR of cases were 4.6 (95% CI, 4.1-5.2) and 3.3 (2.6-4.2) and the IRR of admissions were 3.3 (2.7-4.2) and 3.8 (2.3-6.5) in the 2 age groups, respectively, when compared with the winter season 2019-2020. Conclusions: Likely because of immunity debt following COVID-19 restrictions, the summer epidemic was significantly larger than previous winter seasons, most markedly among children aged 2 to 3 and 4 to 5 years but had a similar disease severity spectrum.